NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,602 | -5.9% | 55 | -6.8% | 0.01% | +25.0% |
| Q2 2023 | $5,954 | +9.7% | 59 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,428 | -15.7% | 59 | -16.9% | 0.00% | -20.0% |
| Q4 2022 | $6,441 | +28.8% | 71 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $5,000 | -16.7% | 71 | -5.3% | 0.00% | -20.0% |
| Q2 2022 | $6,000 | -14.3% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $7,000 | +40.0% | 75 | +25.0% | 0.01% | +66.7% |
| Q4 2021 | $5,000 | +25.0% | 60 | +27.7% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 47 | -13.0% | 0.00% | -25.0% |
| Q4 2020 | $5,000 | -61.5% | 54 | -63.0% | 0.00% | -66.7% |
| Q3 2020 | $13,000 | 0.0% | 146 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $13,000 | +225.0% | 146 | +147.5% | 0.01% | +180.0% |
| Q1 2020 | $4,000 | -20.0% | 59 | -1.7% | 0.01% | 0.0% |
| Q4 2019 | $5,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |